Cefadroxil Dry Syrup 50 mg/5 mL (Cefpodoxime Proxetil)

Adult dose

In cases considered severe or insufficiently effective, administer 4.5 mg (as cefpodoxime) per kg of body weight for each dose, 3 times a day, orally.

Child dose

○ Infants and children: Suspend before use and administer orally 2~3 times daily, at a dose of 3mg (potency) of cefpodoxime per kg of body weight per dose. In severe cases or when the effect is considered insufficient, administer 4.5mg (potency) per kg of body weight per dose orally 3 times daily. The dose may be adjusted according to age, symptoms, etc.

This medication contains the artificial sweetener aspartame, which breaks down into phenylalanine in the body. Therefore, it should not be used by patients with phenylketonuria, a genetic disorder that restricts phenylalanine intake. Patients who have experienced severe allergic reactions or shock after using this medication should not be administered it. Additionally, since this medication contains lactose, it should not be used in patients with galactose intolerance, lactase deficiency, or glucose-galactose malabsorption syndrome. Caution should be exercised when administering this medication to patients with a history of allergic reactions to this drug or cephalosporins, those who are allergic to penicillin antibiotics, those with allergic predispositions, patients with severely impaired kidney function, patients who have difficulties with oral administration, elderly patients, or those in poor overall condition. This medication can rarely cause serious allergic reactions such as shock or anaphylaxis; administration should be stopped immediately if symptoms occur. If allergy symptoms such as skin rash, hives, itching, or fever appear, stop taking the medication and seek appropriate treatment. It may affect the gastrointestinal system, leading to symptoms such as abdominal pain, diarrhea, nausea, and vomiting; in severe cases, it can cause pseudomembranous colitis, so administration should be stopped immediately if symptoms appear. Respiratory symptoms and interstitial pneumonia may occur; therefore, inform medical personnel if there are symptoms such as difficulty breathing, cough, or fever. Blood tests may show thrombocytopenia or leukopenia, so regular blood tests are necessary for long-term use. As it may affect the nervous system, leading to cognitive impairment or seizures, patients with impaired renal function may need dosage adjustments and should report any abnormal symptoms immediately. Severe skin reactions may occur, so if any skin symptoms such as rash, blistering, or mucosal abnormalities appear, stop taking the medication and visit a hospital. It may affect liver and kidney function, so regular checkups are necessary to confirm any abnormalities. This medication may lead to dysbiosis such as stomatitis or candidiasis, and vitamin K deficiency may result in a tendency to bleed, so monitor for symptoms. It is advisable to administer this drug only for the minimum required duration to prevent the development of resistant bacteria, and allergy history and skin reaction tests are recommended prior to use. Patients should be cautious while driving or operating machinery as dizziness may occur. If taken for more than 10 days, blood tests should be conducted to confirm leukocyte counts. In patients with impaired kidney function, dosage adjustments are necessary, and if seizures occur, administration should be halted immediately. This medication has been reported to cause severe skin reactions, so consult healthcare professionals immediately if skin symptoms develop. Caution is needed when used with other diuretics or aminoglycoside antibiotics as they may affect kidney function. The concentration of this medication in the blood may vary when combined with certain drugs, so patients should inform healthcare providers of any medications being taken. Its safety during pregnancy has not been established, thus it should be used cautiously when necessary, and breastfeeding should be discontinued if nursing. It is not safe for neonates or infants under 2 months of age as safety has not been confirmed. Elderly patients may have decreased body function, increasing the risk of adverse reactions, so dosages and intervals should be adjusted while monitoring their condition closely. After preparing this medication, it should be stored in a sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This will help preserve the medication's effectiveness for a longer period.

Shock

This medication must be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature. This helps to keep the efficacy of the medication for a longer duration.

Appearance

Pale pink to pale purple granules

Package unit

200 mL/bottle